The Neurological, Mental and Behavioral Health (NMBH) study section reviews applications that address the etiology, determinants, distribution and outcomes of neurological, mental and behavioral conditions and disorders from a population health perspective. Applications reviewed in this study section look to characterize the effect of genetic, epigenetic, biological and environmental factors on the risk, development and progression of these brain-related conditions and disorders. Studies reviewed in NMBH have a population health focus, including consideration of health equity within and across populations. Applications that focus on the pathophysiology or the underlying mechanisms of these conditions and disorders especially those that primarily use animal or other experimental models are reviewed in other study sections.
The membership panel is a list of chartered members only.
- Studies addressing the incidence, prevalence, progression and consequences of neurological diseases and phenotypes in large populations ranging from neurodevelopmental disorders to neurological conditions related to aging
- Studies addressing the incidence, prevalence, progression and consequences of mental health, mental disorders and related phenotypes, behavioral health and behavioral disorders including substance use disorders in large populations
- Studies addressing the incidence, prevalence, progression and consequences of communication and visual disorders and related traits in large populations including abnormalities of hearing, sight, balance, taste, smell, voice, speech and language
- Studies of incidence, prevalence and determinants of co-morbidities and multi-morbidities with neurological, mental and behavioral conditions and disorders in large populations
- Studies examining the effects of environmental and other exposures on incidence, progression, and outcomes related to neurological, mental and behavioral conditions and disorders in large populations, especially with a focus on the disease or disorder outcome rather than the exposure
- Applications may use methodologies and study designs including cohort, case-control, prospective, longitudinal, retrospective, clinical trial, cross-sectional, surveillance, omics (i.e. genomics, transcriptomics, proteomics, metabolomics, epigenomics, metagenomics) and assessment of gene-environment interactions
Shared Interests and Overlaps
There are shared interests in age-related conditions such as Alzheimer’s disease with Aging, Injury, Musculoskeletal and Rheumatologic Disorders (AIMR). Applications that primarily focus on characterizing the determinants of neurological diseases and disorders are reviewed in NMBH. Applications that emphasize the process of aging and how aging affects the development, progression and consequences of neurological disorders and conditions are reviewed in AIMR.
There are shared interests in substance use with a population-based focus with Lifestyle and Health Behaviors (LHB). Applications that emphasize behavioral health conditions or disorders as the health outcome, for example applications focusing on substance use disorders, are reviewed in NMBH. Applications that focus on health behaviors as an exposure or health outcome are in LHB, for example applications focused on substance use or how substance use affects other health outcomes.
There are shared interests in social or environmental epidemiology applications that assess behavioral, mental and neurological outcomes with Social and Environmental Determinants of Health (SEDH). Applications that focus on behavioral, mental and neurological health conditions and disorders at the population level incorporating environmental and/or social exposures as risk factors can be reviewed in NMBH. Applications that focus on the characterization of environmental and/or social determinants or exposures that contribute to behavioral, mental and neurological health conditions at the population level can be reviewed in SEDH.
There are shared interests in neurodevelopmental outcomes of children with Reproductive, Perinatal and Pediatric Health (RPPH). Applications that focus on neurodevelopmental outcomes in children at the population level are reviewed in NMBH. Lifecourse applications that focus on the relationship between prenatal exposures and neurodevelopmental outcomes in the children at the population level are reviewed in RPPH.
There are shared interests in human chronic neurodegenerative and neurocognitive disease with Clinical Neuroscience and Neurodegeneration Study Section (CNN). Applications that emphasize the determinant and predictors for these conditions in human subpopulations including looking the association of biomarkers with health consequences of neurological disease are reviewed in NMBH. Applications that emphasize the mechanisms and clinical management of these conditions, development of therapeutic strategies, and development of biomarkers are reviewed in CNN.
There are shared interests in behavioral and psychiatric conditions with biobehavioral processes study sections Child Psychopathology and Developmental Disabilities (CPDD) and Mechanisms of Emotion, Stress and Health (MESH). Applications that emphasize epidemiological study designs to examine determinants, predictors, and biomarkers associated with behavioral, psychiatric and substance use disorders exclusively in human subpopulations are reviewed in NMBH. Applications that emphasize the neurological foundations underlying these conditions in both experimental animal models and humans are reviewed in the biobehavioral processes study sections.
There are shared interests in studying the genetic predisposition to disease using population-based samples with Genetics of Health and Disease (GHD). Applications that emphasize how these factors contribute to health outcomes in human subpopulations are reviewed in NMBH. Applications that emphasize discovery of genetic, genomic, epigenomic elements and molecular signatures are reviewed in GHD.